Calidi Biotherapeutics, Inc.

Q2 2025 13F Holders

Symbol
CLDI
CUSIP
320703309
Type
Equity
Class
COM NEW
Num filings
37
Total reported value, excl. options
$657 k
Manager Report Date Value ($000) Shares Option Type